Trials / Completed
CompletedNCT00259233
The Role of Peptide YY (PYY)in Inhibiting Food Intake.
The Effects of Peripheral Administration of Saline, PYY1-36 and PYY3-36 on ad Libitum Energy Intake and Appetite.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (planned)
- Sponsor
- University of Copenhagen · Academic / Other
- Sex
- Male
- Age
- 20 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
12 obese subjects will receive peripheral administration of placebo and 4 escalating doses of PYY1-36 and another 12 obese subjects will receive peripheral administration of placebo and 4 escalating doses PYY3-36 on 5 different test days within one week. The patients will be tested in a single blinded dose escalating protocol. Measurements of appetite, ad libitum energy intake, blood pressure and blood sampling will be performed during the test day.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | peripheral Peptide YY administration |
Timeline
- Start date
- 2005-03-01
- Completion
- 2005-05-01
- First posted
- 2005-11-29
- Last updated
- 2009-01-21
Source: ClinicalTrials.gov record NCT00259233. Inclusion in this directory is not an endorsement.